BSEBoard Meeting5d ago · 14 Aug 2026, 06:25 pm

Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations, 2015

ANG Lifesciences India Ltd · 540694

✦ AI Summary▼ NegativeResults

ANG Lifesciences India Ltd has submitted its standalone and consolidated unaudited financial results for the quarter ended 30.06.2026. The company reported a loss before exceptional items and tax of ₹577.95, with a total tax expense of ₹133.53. The loss for the period was ₹424.42. The company's revenue from operations was ₹1,529.77, with a total revenue of ₹1,540.54.

Analysis Scores

Earnings Impact2/10
Growth Catalyst5/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk6/10
Liquidity Impact8/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015

Attachments (1)

📄

7a900f30-7e23-4e88-af56-be77291f29f2.pdf

pdf

Download →
View document text
C I N No : - L24230P82006P1C03034 1 GST No:- 02AAHCA5390H2ZT ANG LITT'CITNCIS INDIA L!MITED Rer. No. .Artt ]lt'nf oate...l.9.-..0. I .:. 2A%. Department of Corporate Services, BSE Limited P J Towers, Dalal Street, Mumbai- 400001 Ref: BSE Security Code: 540694 Sub: Outcome of Board Meeting pursuant to Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations. 20 I 5. Dear Sir/Madam, With reference to the cited subject, rve would like to inform you that the Board of Directors of the Company at its meeting held on today i.e., l4th August,2026, have inter- alia, transacted and approved the fol lowing: 1. The Standalone and Consolidated Un-audited Financial Results for the quafter ended 30th June,2026. Z. Limited Review Report forthe first quarter ended as at 3Oth June,2026 and a copy of the same is enclosed. please note that the Un-Audited Standalone & Consolidated Financial Results lor the first quarter ended 30th Jpne 2026have been reviewed by the Audit Committee and subsequently approved and takeri on record by the Board of Directors in its meeting held on 14th August2026. The meeting commenced at 05:00 PM and concludedat OO: t5 PM ' Please take the above information on your record' 1'hanking you. YourS Faithfully, India Limited. Regd. Office: SCO-.l.l3, DARBARA COM PLEX, First Floor, B- BLOCK, Ranjit Avenue, Amritsar-14300' Works: (UNtT-t) Village kishanpura, P.O: Manpura Nalagarh Road, Tehsil: Baddi, Distt.' Solan (H P)-17410.| Works: (UNtrltV)Kh.No.'139l2,VillageJodhapur,Barotiwala,BaddiTehsilNalagarhDistt.'Solan(HP)-.l74105 Works: (UNIT-V)Village Malkumajra, Nalagarh Road, BaddiTehsilNalagarh Distt.: Solan (HP)-'l75205 ph. Ot83-513345,5133458. E mail: operations@angli'fesciences.com, Website: www.anglif esciences.cqm C I N No: - L24230P82006 PLC 03034 1 GST No:- 02AAHCA5390H2ZT ANG LIITSCItNTtS INDIA LIMITED Ref. No. Date........ Statement of stafdalone unaudited results for the ended 30 June 2026 in lakhs except per share dato) Quarter ended Quarter ended Quarter ended Year ended )articu Iars 30 June 2026 31 March 2026 30 June 2025 3i March 2o26 (Audited, as (Unaudited) exolained in note 4) (Unaudited) {Audited) I Revenue from operations 1,395.79 2,280.01 2,453.18 9,'t60.45 il Other income 19.?6 18.78 17.34 72.66 ilt Total revenue (l+ll) 1,415.O5 2,298.79 2,470.52 9,233.11 IV Expenses Cost of materiats consumed 857.50 1,100.40 1,644.90 5,507.58 Changes in inventories of finished goods and work-in-progress 77.77 194.00 (25.30) 321.04 Emptoyee benefits expense 346.92 331.70 349.43 1,434.64 Finance costs 177.13 164.86 160.62 644.84 Depreciation and amortisation expenses 1 46.89 172.91 144.62 608. 1 8 Other expenses 259.96 191.96 298.92 1,235.92 Total expenses (lV) 1,866.17 2,1 55.83 2,573.19 9,752,20 Profit/(Loss) before exceptional items and tax (lll-lV) (451.12) 142.96 (1O2.671 (51e.0e) . 1': VI ExceptionaI items vll Profit/(Loss) betore tax (V-Vl) (451 .12) 142.96 (102.67l, (sl 9.09) Tax expense (1 ) Current tax (2) Deferred tax ( 1 09.36) 37.71 (23.94) (46.45) vlll Total taxexpense (1+2)'. (1 0e.36) 32.71 (23.e4) (46.451 IX Profit/(Loss) for the period (Vll-Vlll) , (341.76) 110.25 (78.73\ 1472.64), X Other comprehensive income: Items that witl nbt be rectassified to profit or (loss) " 4.48 10.04 2.63 17.93 lncome tax relating to items that witt not be rectassified to profit or toss (1.13) (2.s2. (0.66) (4.51 xl Total comprehensive ineome/(toss) (lX+X) (338.41) 117 .77 (76.76) (459.22\ xil Paid-up,qqqllyshare capitat (Facevatue t 1Ol- per r 1,305.83 1,305.83 1,305.83 1,305.83 xilr other equity 4,915.85 xtv Earnings/(Loss) per equity share (of t 10/- each) is -Basic and dituted r-v' (2.59) 0.90 (0.591 (3.52r See accompanying notes to the financial results. Regd. Officer SCO-'l'13, DARBARA COM PLEX, First Floor, B: BLOCK, RanjitAvenue, Amritsar-1430 Works:(UNIT-l)Villagekishanpura,P.O:ManpuraNalagalhRoad,Tehsil,Baddi,Distt.:Solan(HP)-174i0.| Works: (UNtT-'tV)Kh.Nb.'139l2,ViltageJodhapur,Barotiwala,BaddiTehsilNalagarhDistt.,Solan(HP)-174103 ' ' Worksr(UNIT-V)VillageMalkumajra,NalagarhRoad,BaddiTehsilNalagarhDistt.:Solan(HP)-'l73205 ph. Ol81-515545, 5133.458. E mail I operations@a nglif esciences.com, Website: www.anglif esciences.com C lN No: - L24230P82006P1C030341 GST No:- 02AAHCA5390H2ZT ANG LIITSCIINCTS lNDIA LIMITED Ref. No. Date Statement of consolidated unaudited results for the ended 30 Jun2026 share Quarter ended Quarter ended (luarter endect Year ended 30 Jun 2026 31 March 2026 30 Jun 2025 31 March 2026 Particulars (AUOtteo, as explained in note (Unaudited) 4) (Unaudited) (Audited) I Revenue from operations 1,529.77 ?,350.22 2,460.36 9,289.78 il 0ther income 10.76 17.11 8.90 54.40 ilt Total revenue (l+ll) 1,54O.54 2,367.33 2,469.26 9,343.68 IV Expenses Cost of materiats consumed 965.1 3 1,249.08 1,647..76 5,733.77 Changes in inventories of finished goods and work-in-progress 76.96 102.45 (20.42) 320.28 Employee benefits expense 397.82 359.79 436.31 1,653.91 Finance costs 223.51 217.78 1 93.69 793.42 Depreciation and amortisation expenses 149.91 176.94 152.78 612.73 Other expenses 290.16 372.23 337.26 1,510.64 Total expensgs (lV) 2,O98.49 2,477.77 2,742.38 10,644.75 Loss before exceptional items and tax (lll-lV) (ss7.9 5) (11O.44) (273.13\ (1,301.06) ,, . i:l VI ExceptionaI items vil Loss before tax (V-Vl) (ss7.9s) (110.44) (273.13) (1,301.06) (1 ) Current tax (2) Deferred tax (1 33. s3) 77.73 (72.51) rr sz. ssl vilt Total tax expense (1+2) ( 1 33. s3) 77.73 (72.51) ( 1 e2. se) tx Loss for the oeriod (Vll-Vlfl) (424.42) (1 38.1 8) (200.62) (1,108.48) x Other comprehensive income: Items that witt not be reclassified to profit or (toss) 2.37 (2.251 2.63 9.49 lncome tax retating to items that witL not be rectassified to profit or loss . (0.60) 0.57 (0.65) (2.391 xt Total corhprehensive income (lX+X) (422.651 (1 3e.8s) (1 98.6s] (1,101.37) xil Paid-up equity share capital (Face ,value t 1 0/ - per share) \ 1,305.83 1,305.83 1,305.83 1,305.83 xilt Other equity xtv Earnings per equity share (of { '10l- each) a o) l B oa its uic feo "'' I i ,324) ( (1 1. 0 07 7) ) ( 11 1 . s a2 ?l ' ( (8 8. 4 43 1 Regd. Of fice: SCO-1'13, DAR BARA COM PLEX, First Floor, B:- BLOCK, Ranjit Avenue, Amritsar-14300 Works:(UNIT-l)Villagekisha.npura,P.O:ManpuraNalagarhRoad,Tehsil:Baddi,Distt.:Solan(HP)-l74l0l * Works: (UNtT:tV) Kh. Nb,139/2, Village Jodhapur, Barotiwala, BaddiTehsil Nalagarh Distt.: Solan (HP)-174t03 , Worksr(UNIT-V)VillageMalkumajra,NalagarhRoad,BaddiTehsilNalagarhDistt.:Solan(HP)-.l73295 Ph,0183.513345,5133458. E mailr operations@angliTesciences.com, Website: www,anglifesciences.com C lN No:- L24230P82006P1C030341 GST No:- 02AAHCA5390H2ZT ANG LIII'CIINCTS INDIA LIMITED Ref. No. Date As per lnd-AS 108, Operating Segments have been defined and presented based on the regutar review by the Company's Chief Operating Decision Maker to assess the performance of each segment and to make decision about attocation of resources. The accounting principles used in the preparation of the consotidated unaudited financial results are consistentty apptied to record revenue and expenditure in individual segments. Accordingly, the consolidated unaudited segment wise revenue, results, assets, and tiabitities is as follows : Quarter ended Year ended 30 June 31 March 30 June 31 March S.No. Particu lars 2026 2026 202s 2026 (Unaudited) (Unaudited) (Unaudited) (Audited) 1 Segment revenue a) Pharmaceuticats 1,395.79 2,280.01 7,453.17 9,160.45 b) Printine and packaqinqs 211.94 172.56 34.35 486.22 Total 1,607.73 2,452.5t 2,487.52 9,646.67 Less: lnter seqment revenue 77.96 107.34 27.16 357.39 Revenue from operations 1,529.77 2,350.23 2,460.36 9,289.28 2' Segment results (profit before tax and finance cost from each segment) a) Pharmaceuticals (273.96 307.79 57.96 175.72 b) Printine and oackaqines (47.67 (187.94 (1 25.53 (584.87 Total (321.63) I 19.8s (67.58) (4s9.1s) Less: Finance costs 236.32 230.29 205.56 841.93 Loss before tax (557.95) 110.44) (273.13) [Showing first 8,000 characters — download PDF for full document]